FTRE
Fortrea Holdings Inc.
Key Financials
Net Income
$-986200000
↓ 200.2%
Operating Income
$-872600000
↓ 439.0%
Revenue
$2.7B
↑ 1.0%
Cash & Equivalents
$174.6M
↑ 47.3%
EPS (Diluted)
$-10.81
↓ 194.6%
Total Assets
$2.7B
↓ 24.1%
Shareholders' Equity
$563.5M
↓ 58.6%
Total Liabilities
$2.2B
↓ 2.9%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 8-K | 6/26/2026 | View on SEC |
| 4 | 6/12/2026 | View on SEC |
| 4 | 6/12/2026 | View on SEC |
| 4 | 6/12/2026 | View on SEC |
| 4 | 6/12/2026 | View on SEC |
| 4 | 6/12/2026 | View on SEC |
| 4 | 6/12/2026 | View on SEC |
| 4 | 6/12/2026 | View on SEC |
| 4 | 6/12/2026 | View on SEC |
| 8-K | 6/12/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | FTRE |
| Company Name | Fortrea Holdings Inc. |
| CIK | 1965040 |
| Sector | Services-Medical Laboratories |
| Industry | Accelerated filer |
| Exchange | Nasdaq |
| SIC Code | 8071 |
| SIC Description | Services-Medical Laboratories |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| Phone | 877-495-0816 |